Changes of non-invasive markers and FibroScan values during HCV treatment-Reference-Cited by-同舟云学术

Changes of non-invasive markers and FibroScan values during HCV treatment

Published:2009-02 Issue:2 Volume:16 Page:132-140
ISSN:1352-0504
Container-title:Journal of Viral Hepatitis
language:en
Short-container-title:

Author:

Vergniol J.,Foucher J.,Castéra L.,Bernard P.-H.,Tournan R.,Terrebonne E.,Chanteloup E.,Merrouche W.,Couzigou P.,de Lédinghen V.

Publisher

Wiley

Subject

Virology,Infectious Diseases,Hepatology

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1111/j.1365-2893.2008.01055.x/fullpdf

Reference30 articles.

1. Peginterferon alfa-2a plus ribavirin for chronic hepatitis C virus infection;Fried;N Engl J Med,2002

2. Peginterferon alfa-2b plus ribavirin compared with interferon alfa-2b plus ribavirin for initial treatment of chronic hepatitis C: A randomised trial;Manns;Lancet,2001

3. Peginterferon-alpha2a and ribavirin combination therapy in chronic hepatitis C: A randomized study of treatment duration and ribavirin dose;Hadziyannis;Ann Intern Med,2004

4. Two-year biochemical, virological, and histological follow-up in patients with chronic hepatitis C responding in a sustained fashion to interferon alfa-2b treatment;Reichard;Hepatology,1995

5. Biochemical and virological outcome of patients with chronic hepatitis C treated with interferon alfa-2b for 6 or 12 months: A 4-year follow-up of 211 patients;Manesis;Hepatology,1997

Cited by 87 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. EASL position paper on clinical follow-up after HCV cure;Journal of Hepatology;2024-08

2. AASLD Practice Guideline on imaging-based noninvasive liver disease assessment of hepatic fibrosis and steatosis;Hepatology;2024-03-15

3. AASLD Practice Guideline on blood-based noninvasive liver disease assessment of hepatic fibrosis and steatosis;Hepatology;2024-03-15

4. Non-invasive Assessment of Liver Fibrosis Regression in Patients with Chronic Hepatitis B: A Retrospective Cohort Study;Infectious Diseases and Therapy;2022-12-15

5. Longitudinal Assessment of the Enhanced Liver Fibrosis Score in the Era of Contemporary HIV and Hepatitis C Virus Treatment;The Journal of Infectious Diseases;2022-08-11